Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice
December 1st, 2017
17K views
The established model of transurethral catheterization of mice allows the study of bladder pathologies, including urinary tract infection, but can only be performed in females. A new model of male transurethral instillation, presented here, will enable research in an area marked by strong clinical and epidemiological differences between the sexes.
Overview
This study introduces a novel model for male transurethral instillation in mice, enabling research into urinary tract infections (UTIs) and bladder pathologies. The method addresses the limitations of existing models that only apply to female mice, allowing for comparative studies between sexes.
Key Study Components
Area of Science
- Neuroscience
- Urology
- Immunology
Background
- Existing models for studying UTIs are limited to female mice.
- Male and female responses to UTIs may differ significantly.
- Understanding these differences is crucial for developing effective treatments.
- The new model allows for the exploration of male-specific bladder pathologies.
Purpose of Study
- To investigate the immune response to urinary tract infections in male mice.
- To facilitate comparisons between male and female immune responses.
- To provide insights applicable to other diseases, such as bladder cancer.
Methods Used
- Preparation of pediatric intravenous access cannulas for instillation.
- Transurethral catheterization of male mice.
- Establishment of infection via natural routes.
- Assessment of immune responses to urinary tract infections.
Main Results
- The new model successfully establishes UTIs in male mice.
- It allows for the study of immune responses specific to male physiology.
- Insights gained can inform future research on bladder cancer.
- Demonstrates the feasibility of male transurethral instillation.
Conclusions
- The male transurethral instillation model is a valuable tool for UTI research.
- It enhances understanding of sex-based differences in immune responses.
- This method can broaden the scope of research in bladder pathologies.
Frequently Asked Questions
What is the significance of studying UTIs in male mice?
Studying UTIs in male mice helps to understand sex-based differences in immune responses, which is crucial for developing targeted treatments.
How does this new model differ from existing models?
This model allows for the study of male mice, whereas existing models are limited to females, enabling comparative research.
What are the potential applications of this research?
The findings can inform treatments for UTIs and other bladder pathologies, including bladder cancer.
What methods are used in this study?
The study utilizes transurethral catheterization and pediatric intravenous access cannulas for infection establishment.
Can this model be used for other diseases?
Yes, it can also be applied to research on other diseases such as bladder cancer.
What are the main results of this study?
The model successfully establishes UTIs in male mice and provides insights into male-specific immune responses.
Executive Industry Relevance
This method enables sex-comparable urinary tract infection modeling in mice, addressing a critical gap in preclinical immunology and urology research. By allowing direct comparison of male and female host responses, it supports mechanistic de-risking of sex-biased disease mechanisms and improves translational confidence in bladder-targeted therapeutics. The approach enhances preclinical model relevance for urinary tract infections and associated bladder pathologies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of sex-specific immune responses in urinary tract infection models.
- Operational Value: Provides a standardized method for transurethral instillation in both male and female mice.
- Strategic Value: Supports hypothesis testing of sex-biased pathways in mucosal immunity and bladder disease.
Screening & Assay Development
- Scientific Value: Generates reproducible bladder tissue preparations for flow cytometry-based immune profiling.
- Operational Value: Delivers quantifiable immune cell infiltration data from infected bladder homogenates.
- Strategic Value: Enables assay standardization for comparative immunology screening across sex and treatment groups.
Translational & Preclinical Research
- Scientific Value: Facilitates disease-relevant system modeling of urinary tract infection with sex parity.
- Operational Value: Supports longitudinal immune response tracking from early to established infection.
- Strategic Value: Improves predictive confidence in preclinical efficacy and safety assessments of bladder-targeted candidates.
Pipeline & Workflow Integration
The method integrates into discovery biology workflows by enabling sex-inclusive immune response profiling in urinary tract infection models, supporting downstream target validation and mechanistic de-risking efforts.
- Discovery Biology: Supports hypothesis testing of sex-differential immune mechanisms in mucosal infection models.
- Screening: Enables standardized, reproducible preparation of bladder tissue for immune cell quantification via flow cytometry.
- Analytics: Generates quantitative immune cell frequency and bacterial burden readouts for comparative group analysis.
- Translational Research: Connects discovery-phase immune profiling to preclinical continuity through sex-comparable disease modeling.
- Enterprise Reuse: Establishes a reusable platform for studying sex-biased immune responses in bladder-associated diseases beyond UTI, including cancer.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in sex-specific immune responses to urinary tract infection.
- Operational Value: Standardizes catheterization and infection procedures across male and female mouse cohorts.
- Strategic Value: Informs go/no-go decisions by revealing sex-based differences in target engagement and pathway modulation.
- Portfolio Impact: Enables risk-adjusted prioritization of therapeutics based on sex-stratified preclinical efficacy and safety profiles.
Implementation Considerations
- Requires expertise in murine anesthesia, catheterization techniques, and aseptic surgical procedures.
- Depends on access to pediatric intravenous cannulas, flow cytometry equipment, and bacterial culture infrastructure.
- Necessitates cross-team standardization between animal handling, microbiology, and immunology teams for reproducible results.
- Involves adaptation considerations for different mouse strains, ages, and pathogen variants in infection modeling.
- Practical limitations include a learning curve for consistent catheter placement and instillation quality scoring, as noted in the source material.
Biopharma FAQs
Why does instillation quality scoring matter for infection consistency?
Instillation quality scoring evaluates the success of bacterial delivery into the bladder, with lower scores indicating potential leakage. The study found that even suboptimal instillations did not significantly affect bacterial colonization at 24 hours, supporting methodological robustness.
How does transurethral catheterization enable natural route infection?
The method establishes infection via the urethra, mimicking the natural ascending route of uropathogenic E. coli in urinary tract infection. This avoids artificial routes like intravesical injection and improves physiological relevance of the model.
What does flow cytometry of bladder tissue reveal about immune response?
Flow cytometry quantifies immune cell infiltration, particularly CD45-positive cells, in infected bladder tissue. The study showed a statistically significant increase in immune infiltration in infected female mice compared to naive controls.
Why are replication requirements important for sex-comparative studies?
Replication ensures that observed differences in immune response between male and female mice are reliable and not due to technical variability. Consistent infection establishment across sexes enables valid comparative analysis of host-pathogen interactions.
What statistical analysis is used to assess bacterial burden across instillation quality groups?
The study used a nonparametric Kruskal-Wallis test to compare bacterial CFU across instillation quality scores, followed by Dunn's test for multiple comparisons correction. This approach determined that leakage during instillation did not significantly impact colonization at 24 hours.
Chapters in this video
0:05
Title
0:47
Preparation of Catheters and Uropathogenic E. coli for Infection
2:08
Transurethral Instillation of Female Mice
3:43
Transurethral Instillation of Male Mice
4:56
Determination of CFU in Infected Organs
6:09
Flow Cytometric Analysis of Bladder Tissue
8:31
Results: Transurethral Catheterization to Induce Urinary Tract Infections
9:57
Conclusion
